| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |